Bedaquiline: a review of human pharmacokinetics and drug-drug interactions
van Heeswijk, R P G, Dannemann, B, Hoetelmans, R M W
Published in Journal of antimicrobial chemotherapy (01.09.2014)
Published in Journal of antimicrobial chemotherapy (01.09.2014)
Get full text
Journal Article
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
DIACON, A. H, DONALD, P. R, LOUNIS, N, MEYVISCH, P, ANDRIES, K, MCNEELEY, D. F, PYM, A, GROBUSCH, M, PATIENTIA, R. F, MAHANYELE, R, BANTUBANI, N, NARASIMOOLOO, R, DE MAREZ, T, VAN HEESWIJK, R
Published in Antimicrobial Agents and Chemotherapy (01.06.2012)
Published in Antimicrobial Agents and Chemotherapy (01.06.2012)
Get full text
Journal Article
Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
RUSTOMJEE, R, DIACON, A. H, KEPT, A, DE BEULE, K, DONALD, P. R, MCNEELEY, D. F, ALIEN, J, VENTER, A, REDDY, C, PATIENTIA, R. F, MTHIYANE, T. C. P, DE MAREZ, T, VAN HEESWIJK, R, KERSTENS, R
Published in Antimicrobial Agents and Chemotherapy (01.08.2008)
Published in Antimicrobial Agents and Chemotherapy (01.08.2008)
Get full text
Journal Article
A Review of Low-Dose Ritonavir in Protease Inhibitor Combination Therapy
Cooper, C. L., van Heeswijk, R. P. G., Gallicano, K., Cameron, D. W.
Published in Clinical infectious diseases (15.06.2003)
Published in Clinical infectious diseases (15.06.2003)
Get full text
Journal Article
Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers
PHAM, P. A, LA PORTE, C. J. L, CAMERON, D. W, LEE, L. S, VAN HEESWIJK, R, SABO, J. P, ELGADI, M. M, PILIERO, P. J, BARDITCH-CROVO, P, FUCHS, E, FLEXNER, C
Published in Antimicrobial Agents and Chemotherapy (01.10.2009)
Published in Antimicrobial Agents and Chemotherapy (01.10.2009)
Get full text
Journal Article
The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir
la Porte, C J L, Li, Y, Béïque, L, Foster, B C, Chauhan, B, Garber, G E, Cameron, D W, van Heeswijk, R P G
Published in Clinical pharmacology and therapeutics (01.10.2007)
Published in Clinical pharmacology and therapeutics (01.10.2007)
Get more information
Journal Article
Relaxivity of liposomal paramagnetic MRI contrast agents
Strijkers, G J, Mulder, W J M, van Heeswijk, R B, Frederik, P M, Bomans, P, Magusin, P C M M, Nicolay, K
Published in Magma (New York, N.Y.) (01.09.2005)
Published in Magma (New York, N.Y.) (01.09.2005)
Get full text
Journal Article
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience
VAN HEESWIJK, R. P. G, VELDKAMP, Al, MULDER, J. W, MEENHORST, P. L, LANGE, J. M. A, BEIJNEN, J. H, HOETELMANS, R. M. W
Published in Antiviral therapy (01.12.2001)
Get full text
Published in Antiviral therapy (01.12.2001)
Journal Article
Absence of circadian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV‐1‐infected patients
Van Heeswijk, R. P. G., Bourbeau, M., Seguin, I., Giguere, P., Garber, G. E., Cameron, D. W.
Published in British journal of clinical pharmacology (01.04.2005)
Published in British journal of clinical pharmacology (01.04.2005)
Get full text
Journal Article
T-25 Drug interaction profile of telaprevir
Garg, V, Kauffman, R.S, Beumont, M, Van Heeswijk, R
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
Producing over 100 ml of highly concentrated hyperpolarized solution by means of dissolution DNP
Comment, A., Rentsch, J., Kurdzesau, F., Jannin, S., Uffmann, K., van Heeswijk, R.B., Hautle, P., Konter, J.A., van den Brandt, B., van der Klink, J.J.
Published in Journal of magnetic resonance (1997) (01.09.2008)
Published in Journal of magnetic resonance (1997) (01.09.2008)
Get full text
Journal Article
1245 THE EFFECT OF SEVERE RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
van Heeswijk, R, Vandevoorde, A, Boogaerts, G, De Paepe, E, van Solingen-Ristea, R, Garg, V, Beumont, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1244 THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
van Heeswijk, R, Vandevoorde, A, Verboven, P, Boogaerts, G, De Paepe, E, van Solingen-Ristea, R, Garg, V, Beumont, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
OP12 Similar Svr Rates In Il28b Cc, Ct Or Tt prior relapser, partial- or null-responder patients treated with telaprevir/peginterferon/ribavirin: retrospective analysis of the Realize Study
Foster, G R, Pol, S, Aerssens, J, Zeuzem, S, Andreone, P, Lawitz, E J, Roberts, S, Younossi, Z, Focaccia, R, Horban, A, Pockros, P J, Van Heeswijk, R, de Meyer, S, Luo, D, Beumont, M, Picchio, G
Published in Gut (01.09.2011)
Published in Gut (01.09.2011)
Get full text
Journal Article
P1221 PHARMACOKINETIC (PK) DRUG–DRUG INTERACTION BETWEEN SAMATASVIR (IDX719), A PAN-GENOTYPIC NS5A INHIBITOR, AND SIMEPREVIR IN HEALTHY VOLUNTEERS AND HCV-INFECTED SUBJECTS
Zhou, X.J, Donovan, E, Chen, J, van Heeswijk, R, Sullivan-Bólyai, J.Z, Mayers, D
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION
Foster, G.R, Zeuzem, S, Andreone, P, Pol, S, Lawitz, E.J, Diago, M, Roberts, S, Pockros, P.J, Younossi, Z, Lonjon-Domanec, I, Van Heeswijk, R, de Meyer, S, Luo, D, George, S, Beumont, M, Picchio, G
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
5 REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN
Zeuzem, S, Andreone, P, Pol, S, Lawitz, E.J, Diago, M, Roberts, S, Focaccia, R, Younossi, Z.M, Foster, G.R, Horban, A, Pockros, P.J, Van Heeswijk, R, de Meyer, S, Luo, D, Picchio, G, Beumont, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY
Pol, S, Aerssens, J, Zeuzem, S, Andreone, P, Lawitz, E.J, Roberts, S, Younossi, Z, Foster, G.R, Focaccia, R, Horban, A, Pockros, P.J, Van Heeswijk, R, de Meyer, S, Luo, D, Botfield, M, Beumont, M, Picchio, G
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study
Andreone, P, Roberts, S, Pol, S, Younossi, Z, Diago, M, Lawitz, E.J, Focaccia, R, Foster, G.R, Horban, A, Lonjon-Domanec, I, DeMasi, R, Van Heeswijk, R, Picchio, G, Witek, J, Zeuzem, S
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article